Skip to main content
. Author manuscript; available in PMC: 2019 Jun 5.
Published in final edited form as: Appl In Vitro Toxicol. 2018;4(4):365–378. doi: 10.1089/aivt.2017.0005

Table 2.

Fitted depletion rate constants (kdep; 1/h) from S9 optimization studies

Phenanthrene Pyrene Benzo[a]pyrene
Incubation timea
 0 h 1.76 ± 0.03 23.00 ± 0.99 36.58 ± 0.62
 0.5 h ----- 18.00 ± 0.54 33.97 ± 1.22
 1 h 1.24 ± 0.00 14.47 ± 0.09 29.59 ± 0.67
 2 h 0.82 ± 0.01 9.88 ± 0.49 23.91 ± 0.40
 3 h 0.63 ± 0.01 7.07 ± 0.40 17.95 ± 0.78
Acetone spiking solventb,c
 0.25% 1.73 ± 0.05d
 0.5% 1.77 ± 0.02d
 1.0% 1.49 ± 0.04e
 2.0% 0.91 ± 0.03f
 5.0% 0.36 ± 0.02g
Alamethicin/methanolb
 0 μg/mL/0% 2.72 ± 0.02
 0 μg/mL/0.25% 2.52 ± 0.01***
 10 μg/mL/0.25% 2.43 ± 0.02***
 25 μg/mL/0.25% 2.20 ± 0.03***
 50 μg/mL/0.25% 1.81 ± 0.03***
a

The nominal starting concentrations of phenanthrene, pyrene, and benzo[a]pyrene were 0.045 μM, 0.03 μM, and 0.005 μM, respectively.

b

The nominal starting concentration of phenanthrene was 0.035 μM.

c

The letters d–g denote sample means that differ statistically from one another, p < 0.01.

***

Significantly different from the control mean (0 μg/mL alamethicin/0% methanol), p < 0.01.